Pear Therapeutics Current Cash

Pear Therapeutics (PEAR) currently reports a current cash of $48M as of December 2022. That compares with $170M in the prior-year period — down 71.5% year over year. Use the charts on this page to explore Pear Therapeutics's current cash history and peer comparisons.

Pear Therapeutics's current cash decreased from $170M to $48M — a 71.5% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Pear Therapeutics reported $48M in current cash as of December 2022. That compares with $170M in the prior-year period — down 71.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $48M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Pear Therapeutics, and consider following PEAR for alerts when major investors trade the stock.